摘要
1988年6月～1992年1月经导管肝动脉灌注化疗及栓塞术治疗不能切除的原发性肝癌70例,男64例,女6例.年龄23岁～66岁,中位年龄47.6岁.Ⅱ期57例,Ⅲ期13例.采用Seldinger氏插管法.治疗方式分3种:TAI、LP—TAE及LP+GS-TAE.经治疗80％病人临床症状改善,疼痛减轻或消失,肿瘤缩小.67.6％病人AFP降低或转阴.生存期延长,半年、1年、2年及3年总生存率分别为62.1％(41/66)、42％(21/50)、34.6％(9/26)及31.6％(6/19).研究表明LP十GS-TAE对不能手术切除的肝癌患者应作为首选疗法.
Seventy patients with unresectablc primary liver cancer were treated with transcatheter hepatic artery infusion and embolization during the period from June 1988 to January 1992. 64 patients were males and 6 females and aged 23-66 years(mean47. 6 years). Fifty-seven cases of this series were of stage Ⅱ disease and 13 stage Ⅲ. Seldinger needle was used to insert the catheter in the femoral artery. In 80% of the patients symptoms and pains were ameliorated and tumor size reduced after treatment. In 67. 6% of cases,AFP values were either declined or turned negative. The duration of survival were prolonged and the survivals for 6 months and 1, 2and3years rated 62. 1% (41/66), 42% (21/50), 34. 6%(9/26), 31. 6%(6/19)respectively. The findings demonstrated that TAE with lipoidol and jelly foam plus chemotherapeutic agent is a good choice for palliative treatment in patients with unresectable hepatic carcinoma.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
1994年第3期186-188,T000,共3页
Chinese Journal of Clinical Oncology
关键词
癌
肝动脉灌注
肝动脉栓塞
肝肿瘤
Primary hepatic carcinonw Hepatic artery infusion Hepatic artery embolization
